+44 (0)20 3910 4640 hello@symmetron.net
  • Twitter
  • Twitter
Symmetron
  • Services
  • Success stories
  • Therapeutic areas
  • Insights
  • The team
  • Careers
  • Contact
Select Page

Evidence generation and communication in drug development

by Kristen Markus | Aug 13, 2021 | Clinical trial, Evidence generation, Health outcomes, Market access, Medical affairs

Clinical evidence generation: clinical trials Health researchers continually discover new evidence that deepens our understanding of disease processes and progression. This rapidly evolving knowledge must be integrated into ongoing research and development of new...

Evidence synthesis for healthcare decision-making

by Kristen Markus | Aug 13, 2021 | Evidence synthesis, Health outcomes, Healthcare, Market access

What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision makers must continuously re-evaluate the evidence base that informs their thinking. But how can they take into account...
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • Budget impact
  • Clinical trial
  • Cost-effectiveness analysis
  • Evidence generation
  • Evidence synthesis
  • Health economic modelling
  • Health outcomes
  • Healthcare
  • Market access
  • Medical affairs
  • NICE
  • Oncology
  • Services
  • Success stories
  • Therapeutic areas
  • Insights
  • The team
  • Careers
  • Contact
  • Privacy Policy
  • LinkedIn
  • Twitter
© 2021 Symmetron Limited